Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Jun;32(6):844–847. doi: 10.1128/aac.32.6.844

Ciprofloxacin activity in cyst fluid from polycystic kidneys.

L W Elzinga 1, T A Golper 1, A L Rashad 1, M E Carr 1, W M Bennett 1
PMCID: PMC172293  PMID: 3415205

Abstract

Renal cyst infection in patients with polycystic kidney disease (PKD) is often unresponsive to standard antimicrobial therapy, in part because of the failure of most antibiotics to adequately penetrate cyst fluid. Ciprofloxacin, a new quinolone antibiotic, possesses in vitro activity against most pathogens likely to be encountered in renal cyst infection. To study the potential usefulness of ciprofloxacin for the treatment of cyst infection, fluid from 70 cysts was obtained from seven patients with polycystic kidney disease who were receiving the drug. Cysts were categorized as nongradient or gradient by the sodium concentration in the fluid. The ciprofloxacin concentration within cysts was measured, and the cyst fluid bactericidal activity against likely cyst fluid pathogens was determined. The mean (+/- standard error) ciprofloxacin concentration was 12.7 +/- 2.9 micrograms/ml. Preferential accumulation of ciprofloxacin occurred in gradient cysts; these levels exceeded levels in serum by more than fourfold. Cyst fluid bactericidal activity titers were uniformly high against Escherichia coli and Proteus mirabilis, while less activity was observed against Streptococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis.

Full text

PDF
847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRICKER N. S., PATTON J. F. Cystic disease of the kidneys; a study of dynamics and chemical composition of cyst fluid. Am J Med. 1955 Feb;18(2):207–219. doi: 10.1016/0002-9343(55)90236-9. [DOI] [PubMed] [Google Scholar]
  2. Barry A. L., Jones R. N., Thornsberry C., Ayers L. W., Gerlach E. H., Sommers H. M. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid. Antimicrob Agents Chemother. 1984 May;25(5):633–637. doi: 10.1128/aac.25.5.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett W. M., Elzinga L., Pulliam J. P., Rashad A. L., Barry J. M. Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis. 1985 Dec;6(6):400–404. doi: 10.1016/s0272-6386(85)80102-5. [DOI] [PubMed] [Google Scholar]
  4. Chin N. X., Neu H. C. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1984 Mar;25(3):319–326. doi: 10.1128/aac.25.3.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crump B., Wise R., Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother. 1983 Nov;24(5):784–786. doi: 10.1128/aac.24.5.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cuppage F. E., Huseman R. A., Chapman A., Grantham J. J. Ultrastructure and function of cysts from human adult polycystic kidneys. Kidney Int. 1980 Mar;17(3):372–381. doi: 10.1038/ki.1980.43. [DOI] [PubMed] [Google Scholar]
  7. DALGAARD O. Z. Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 1957;328:1–255. [PubMed] [Google Scholar]
  8. Daschner F. D., Westenfelder M., Dalhoff A. Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue. Eur J Clin Microbiol. 1986 Apr;5(2):212–213. doi: 10.1007/BF02013992. [DOI] [PubMed] [Google Scholar]
  9. De Bono D. P., Evans D. B. The management of polycystic kidney disease with special reference to dialysis and transplantation. Q J Med. 1977 Jul;46(183):353–363. [PubMed] [Google Scholar]
  10. Elzinga L. W., Golper T. A., Rashad A. L., Carr M. E., Bennett W. M. Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int. 1987 Dec;32(6):884–888. doi: 10.1038/ki.1987.290. [DOI] [PubMed] [Google Scholar]
  11. Gardner K. D., Jr Composition of fluid in twelve cysts of a polycystic kidney. N Engl J Med. 1969 Oct 30;281(18):985–988. doi: 10.1056/NEJM196910302811804. [DOI] [PubMed] [Google Scholar]
  12. Gonzalez M. A., Uribe F., Moisen S. D., Fuster A. P., Selen A., Welling P. G., Painter B. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1984 Nov;26(5):741–744. doi: 10.1128/aac.26.5.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grantham J. J., Geiser J. L., Evan A. P. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int. 1987 May;31(5):1145–1152. doi: 10.1038/ki.1987.121. [DOI] [PubMed] [Google Scholar]
  14. Huseman R., Grady A., Welling D., Grantham J. Macropuncture study of polycystic disease in adult human kidneys. Kidney Int. 1980 Sep;18(3):375–385. doi: 10.1038/ki.1980.148. [DOI] [PubMed] [Google Scholar]
  15. Jacobsson L., Lindqvist B., Michaelson G., Bjerle P. Fluid turnover in renal cysts. Acta Med Scand. 1977;202(4):327–329. doi: 10.1111/j.0954-6820.1977.tb16837.x. [DOI] [PubMed] [Google Scholar]
  16. LeBel M., Vallée F., Bergeron M. G. Tissue penetration of ciprofloxacin after single and multiple doses. Antimicrob Agents Chemother. 1986 Mar;29(3):501–505. doi: 10.1128/aac.29.3.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Muther R. S., Bennett W. M. Cyst fluid antibiotic concentrations in polycystic kidney disease: differences between proximal and distal cysts. Kidney Int. 1981 Oct;20(4):519–522. doi: 10.1038/ki.1981.170. [DOI] [PubMed] [Google Scholar]
  18. Oppenheimer G. D. Polycystic Disease of the Kidney. Ann Surg. 1934 Dec;100(6):1136–1158. doi: 10.1097/00000658-193412000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Perrone R. D. In vitro function of cyst epithelium from human polycystic kidney. J Clin Invest. 1985 Oct;76(4):1688–1691. doi: 10.1172/JCI112155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rothermel F. J., Miller F. J., Jr, Sanford E., Drago J., Rohner T. J. Clinical and radiographic findings of focally infected polycystic kidneys. Urology. 1977 May;9(5):580–585. doi: 10.1016/0090-4295(77)90262-x. [DOI] [PubMed] [Google Scholar]
  21. Rudin J. E., Norden C. W., Shinners E. M. In vitro activity of ciprofloxacin against aerobic gram-negative bacteria. Antimicrob Agents Chemother. 1984 Oct;26(4):597–598. doi: 10.1128/aac.26.4.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SIMON H. B., THOMPSON G. J. Congenital renal polycystic disease; a clinical and therapeutic study of three hundred sixty-six cases. J Am Med Assoc. 1955 Oct 15;159(7):657–662. doi: 10.1001/jama.1955.02960240023006. [DOI] [PubMed] [Google Scholar]
  23. Schwab S. J., Bander S. J., Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987 Apr;82(4):714–718. doi: 10.1016/0002-9343(87)90005-2. [DOI] [PubMed] [Google Scholar]
  24. Schwab S. J. Efficacy of chloramphenicol in refractory cyst infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1985 May;5(5):258–261. doi: 10.1016/s0272-6386(85)80118-9. [DOI] [PubMed] [Google Scholar]
  25. Schwab S., Hinthorn D., Diederich D., Cuppage F., Grantham J. PH-dependent accumulation of clindamycin in a polycystic kidney. Am J Kidney Dis. 1983 Jul;3(1):63–66. doi: 10.1016/s0272-6386(83)80012-2. [DOI] [PubMed] [Google Scholar]
  26. Sweet R., Keane W. F. Perinephric abscess in patients with polycystic kidney disease undergoing chronic hemodialysis. Nephron. 1979;23(5):237–240. doi: 10.1159/000181642. [DOI] [PubMed] [Google Scholar]
  27. Waters W. B., Hershman H., Klein L. A. Management of infected polycystic kidneys. J Urol. 1979 Sep;122(3):383–385. doi: 10.1016/s0022-5347(17)56421-6. [DOI] [PubMed] [Google Scholar]
  28. Wickre C. G., Bennett W. M. Renal cyst epithelial transport in non-uremic polycystic kidney disease. Kidney Int. 1983 Mar;23(3):514–518. doi: 10.1038/ki.1983.49. [DOI] [PubMed] [Google Scholar]
  29. Wise R., Andrews J. M., Edwards L. J. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother. 1983 Apr;23(4):559–564. doi: 10.1128/aac.23.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wolfson J. S., Hooper D. C. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother. 1985 Oct;28(4):581–586. doi: 10.1128/aac.28.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES